Monday Jul 14 | HAPPI/Household & PP Industry
Allergan Completes Acquisition of Aczone Gel
Allergan, Inc.'s wholly-owned subsidiary, Allergan Sales, LLC, and QLT USA, Inc., a wholly-owned subsidiary of QLT Inc.
A number of Botox users and relatives of those who had the drug administered filed suit in California, claiming that the drug injured or killed.
Allergan failed to warn of dangerous Botox side effects, lawsuit claims
More than a dozen Botox users and relatives filed a lawsuit today contending the blockbuster wrinkle-buster injured them or killed their relatives, and they blamed maker Allergan Inc.
Allergan Wins Appeals Court Ruling Blocking Apotex's Acular LS Generic
Allergan Inc. , maker of the Botox wrinkle treatment, won an appeals court ruling that prevents Apotex Inc.
Public relations, press release distribution, investor relations, SEC filing
Allergan, Inc. invites you to listen to David Pyott, Chairman of the Board and Chief Executive Officer, and Jeff Edwards, Executive Vice - ST.
Scotts Valley--- Compassoft has a New President and Ceo; Paul...
Allergan, Inc. Compassoft, Inc., the leading provider of governance, risk and compliance solutions that automate the management and control of risks associated with the use of spreadsheets, desktop databases ...
Acacia Subsidiary Acquires Rights to Pa...
Irvine-based Allergan sees a boost in its sales of Botox, as more turn to fillers and laser procedures during the economic downturn.... full story AUTOMOBILES Business commuters' guide to best cars Costa ...
In a few short months, Barrier has gone from looking to pick up new compounds itself to entering the fold of privately held Stiefel.
Bad Economy Gives Botox A Lift
The economy may be sagging, but that doesn't mean your skin has to. Yes, despite a spurt of bad press about adverse reactions and all the late-night humor, demand for Botox, the injectable drug used to perk up ...
Allergan Receives U.S. Food And Drug Administration Approval For...
Allergan Receives U.S. Food And Drug Administration Approval For TRIVARIS 80 Mg/mL Main Category: Eye Health / Blindness Also Included In: Regulatory Affairs / Drug Approvals Article Date: 18 Jun 2008 - 15:00 ...
Obesity Surgery for Diabetes Is a Tough Sell
Even as the U.S. government considers paying for weight-loss surgery to treat the most common form of diabetes, the costly procedure will be a tough sell for employers and insurers.
Assess Allergan's continued dependence on its Botox franchise
The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Allergan Cleared To Market Steroid For Retinal Conditions
Cost basis is the cost at which you entered a position or purchased an asset. It is the total price you paid for, say, your house, a stock, mutual fund, etc...--and by total we mean including all commissions, ...
Allergan To Acquire Aczone Gel For; Financial View Unchanged
You're at a fruit market. But, instead of just being able to buy apples at this fruit market, you can also sell fruit.
Zacks Analyst Blog Highlights: Lithia Motors, Ford, General Motors,...
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
Less than a week after announcing plans to beef up its medical cosmetics business , Allergan made another bold move yesterday: acquiring the rights to QLT 's acne drug Aczone.
QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million
QLT Inc. announced today that QLT USA, Inc., its wholly-owned subsidiary, has entered into an asset purchase agreement with Allergan Sales, LLC, a wholly-owned subsidiary of Allergan, Inc.
A treatment for glaucoma has an unusual, and likely very lucrative side effect. It makes eyelashes thicker and longer.
Drug Company Creates Eyelash Thickener
A U.S. drug company said it has developed a cosmetic drug that uses bimatoprost to stimulate eyelash growth.
Allergan to Seek U.S. Approval of Eyelash Growth Drug
Allergan Inc., the maker of the wrinkle remover Botox, said it will ask U.S. regulators by the end of the third quarter to approve a treatment that stimulates eyelash growth.